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Numerous population studies and experimental models suggest that helminth infections
can ameliorate immuno-inﬂammatory disorders such as asthma and autoimmunity.
Immunosuppressive cell populations associated with helminth infections include Treg
and alternatively-activated macrophages. In previous studies, we showed that both CD4
1
CD25
1 Treg, and CD4
– MLN cells from Heligmosomoides polygyus-infected C57BL/6 mice
were able to transfer protection against allergic airway inﬂammation to sensitized but
uninfected animals. We now show that CD4
–CD19
1 MLN B cells from infected, but not
naı ¨ve, mice are able to transfer a down-modulatory effect on allergy, signiﬁcantly
suppressing airway eosinophilia, IL-5 secretion and pathology following allergen
challenge. We further demonstrate that the same cell population can alleviate auto-
immune-mediated inﬂammatory events in the CNS, when transferred to uninfected mice
undergoing myelin oligodendrocyte glycoprotein(p35–55)-induced EAE. In both allergic and
autoimmune models, reduction of disease was achieved with B cells from helminth-
infected IL-10
 /  donors, indicating that donor cell-derived IL-10 is not required. Pheno-
typically, MLN B cells from helminth-infected mice expressed uniformly high levels of
CD23, with follicular (B2) cell surface markers. These data expand previous observations
and highlight the broad regulatory environment that develops during helminth infections
that can abate diverse inﬂammatory disorders in vivo.
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Introduction
The question of if, and how, infection may modulate the severity
of allergic and autoimmune pathologies is steadily gaining
prominence, reﬂecting the continuing rise in prevalence of
immunopathologies, and the evidence for an inverse correlation
between viral, bacterial and parasitic infections with rising
asthma, multiple sclerosis and Crohn’s disease [1–6].
Until recently, the Th1-Th2 dichotomy was invoked to explain
the regulation of immunopathologic disease. Thus, reduced Th1-
associated autoimmune pathologies were observed following
Th2-inducing helminth infections [7–9], while, Th2-driven
allergic reactions are reduced following infection with Th1-
inducing pathogens [10–12]. However, Th2-inducing human
helminth infections are often protective against Th2-mediated
responses to allergen provocation [13–15], while autoimmunity
can be blocked by some bacterial pathogens [16].
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recognition that a balance between immunoregulatory and
effector mechanisms is required to keep allergic or autoimmune
propensities in check [17–21]. Furthermore, we, and others, have
shown that parasitic infections can expand Treg cell populations
[22–27], including the demonstration that adoptively transferred
H. polygyrus-induced CD4
1CD25
1 Treg cells suppress inﬂam-
mation following airway allergen challenge [23].
Although the Treg (CD4
1CD25
1Foxp3
1) is a central
player in the immunoregulatory network, in the contexts of both
airway allergy [28, 29] and autoimmune disease [21, 30], this is
not the only cell population capable of down-regulating immune
responsiveness. Suppressive, alternatively activated macrophages
are able to directly block T-cell proliferation, and are selectively
enhanced by helminth infection [31–34]. Recently evidence has
emerged for B cells expressing regulatory function to control
immune pathologies [35–39], and in the context of helminth
infections in mice [40–43] as well as humans [44].
We accordingly set out to test whether B cells, generated
during chronic H. polygyrus infection, were capable of regulating
allergen-induced airway inﬂammation (AAI), as might be
predicted from our earlier ﬁnding that CD4
  MLN cells (MLNC)
from infected C57BL/6 mice could transfer protection to unin-
fected, allergen-sensitized animals [23]. As shown here,
CD4
 CD19
1 B cells from chronically infected mice can indeed
suppress airway inﬂammation in uninfected recipients, reducing
bronchoalveolar IL-5, eosinophilia and airway pathology.
Furthermore, the same population of CD4
 CD19
1 B cells from
infected donors can, on transfer, signiﬁcantly reduce the severity
of disease during EAE in uninfected recipients. We demonstrate
that in neither setting is IL-10 required from the donor B-cell
population to protect against pathogenic inﬂammation of these
different aetiologies in vivo.
Results
Both CD4
þ and CD4
  MLNC from H. polygyrus-infected
C57BL/6 mice can mediate suppression
H. polygyrus is a natural enteric-dwelling nematode parasite
which establishes a chronic infection in many strains of mice
[45]. We have previously shown that H. polygyrus-infected mice
display signiﬁcantly reduced airway inﬂammatory responses to
OVA or Der p1 allergen provocation in BALB/c and C57BL/6
mice, respectively [23]. Notably, in this system suppression of the
allergic outcome was not associated with a shift from Th2 to Th1
responsiveness. In fact, as demonstrated by adoptive transfer,
MLN CD4
1CD25
1 Treg cells from infected animals of both strains
were able to transfer protection from airway inﬂammation in
uninfected recipients [23].
An intriguing feature of our earlier study [23] was that, in the
C57BL/6 strain, CD4
  MLNC were also able to transfer signiﬁcant
protection against airway allergy. To investigate this further, we
ﬁrst extended studies in the transfer model (Fig. 1A) to compare
airway cell inﬁltration and inﬂammatory cytokine production in
allergic mice receiving CD4
1 (>93% pure) or CD4
  (>97%)
MLNC from H. polygyrus-infected mice, employing an allotypic
difference in CD45 (Ly5) to permit subsequent tracking of
transferred cells [46]. Allergen-sensitized C57BL/6 (CD45.2/
Ly5.2
1) mice received 4 10
6 CD4
1 or CD4
  MLNC from
infected congenic B6-CD45.1 donors i.v. 7 days before the ﬁrst of
two (day 28 and day 31) intratracheal Der p1 airway challenges.
Mice were assessed for airway inﬂammation on day 32.
Der p1 airway challenge of Der p1-sensitized mice incited a
substantial cellular inﬂux into the BALF with a signiﬁcant
proportion of eosinophils, characteristic of allergen-induced
inﬂammation. As previously observed in the C57BL/6 system
[23], CD4
1 and CD4
  MLNC showed equivalent efﬁcacy at
reducing total airway cell inﬁltration (Fig. 1B) and eosinophilia
(Fig. 1C) in recipient mice. Moreover, the two cell populations
were broadly similar in reduction of IL-5 (Fig. 1D) and eotaxin
(Fig. 1E) in the BALF, consistent with the attenuated degree of
eosinophilia.
Because the transferred CD4
  population contains approxi-
mately 70% B cells, we also examined whether total and allergen-
speciﬁc antibody responses were altered in recipient animals.
Neither total nor Der p 1-speciﬁc IgE levels showed signiﬁcant
differences between control allergic mice and those receiving cell
transfers (Fig. 1F and G), as found previously for BALB/c mice
[23]. IgG isotype analysis did indicate a reduction in Th2-asso-
ciated IgG1, and a small increment in Th1-linked IgG2a in the
CD4
  MLNC recipients (Fig. 1H and I), but not at levels that
achieved statistical signiﬁcance.
In addition to the suppression of airway eosinophilia and local
IL-5 and eotaxin secretions, airway pathology was also atte-
nuated. As expected, a dense layer of cells was observed
surrounding the bronchioles and arteries of Der p1-sensitized
mice following Der p1 challenge (Fig. 2A). The adoptive transfer
of CD4
1 or CD4
  cells from chronically infected donors
substantially decreased peri-bronchial and peri-arterial inﬂam-
mation following Der p1 challenge (Fig. 2A). In a further
experiment it was conﬁrmed that down-modulation of airway
inﬂammation and pathology was affected only by CD4
  cells
from infected, and not uninfected, mice (Fig. 2B).
CD4
þ and CD4
  cells from infected donors trafﬁc to
the airways
The CD45 congenic marker permitted us to track the location of
donor cells in recipient mice at the end-point of the experiment.
At day 32, 11 days after the transfer of cells from infected donors,
we found a signiﬁcant accumulation of donor CD4
1 and CD4
 
cells in the airspace, lung tissue and draining thoracic LNs of Der
p1-challenged mice (Fig. 3). These data suggest that both CD4
1
and CD4
  populations migrate to the sites and local draining
nodes responding to allergen provocation and suppress allergen-
induced IL-5 and eotaxin secretion, reducing the recruitment of
eosinophils.
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þ B cells from infected WT and IL-10
 /  mice
suppress allergen-induced airway eosinophilia
MLNC from chronically-infected mice consist of approximately
40% CD4
1 T cells (Supporting Information Fig. 1A, lower left
panel) and a similar proportion of CD19
1 B Cells (Supporting
Information. Fig. 1A, lower right panel). We therefore puriﬁed
CD19
1 B cells, representing the majority of the CD4
  population,
from the MLN of naı ¨ve and chronically infected WT C57BL/6
mice for functional testing in the transfer model (Supporting
Information Fig. 1B). Because of the prominent role of IL-10 in
many B-cell regulatory functions [40, 41, 47] we also puriﬁed
CD19
1 B cells from chronically infected IL-10
 /  mice for assay
in the same system.
CD19
1 B cells were transferred from the MLN of naı ¨ve or
infected mice, into Der p1-sensitized recipients, 7 days before the
ﬁrst of two Der p1 airway challenges. Mice receiving CD19
1 cells
from chronically infected donors had signiﬁcantly fewer cells
inﬁltrating the airspaces following Der p1 challenge while CD19
1
cells from uninfected donors (naı ¨ve) had no effect on airway
inﬁltration (Fig. 4A). Similarly, airway eosinophilia was signiﬁ-
cantly ablated by the introduction of B cells from infected, but not
naı ¨ve, donors. Importantly, the ability of B cells from infected
mice to block allergic reactions was evident in both
total cell numbers and eosinophilia irrespective of IL-10
competence.
Furthermore, secretions of IL-5 and eotaxin recovered from
the airspaces were also signiﬁcantly decreased following the
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Figure 1. CD4
1 and CD4
  cells from helminth-infected donors can suppress Der p1-induced airway inﬂammation. 4 10
6 puriﬁed CD4
1 and CD4
 
MLNC from 28 day H.polygyrus-infected B6-CD45.1 mice were injected i.v. into C57BL/6 (CD45.2
1) recipients that had received Der p1
immunizations 7 and 21 days earlier (day 0 and 14 in (A), respectively). Seven and 10 days after transfer (days 28 and 31, respectively), the mice
were challenged with Derp1 and measurements made 1 day later (day 32). D:D denotes mice receiving Der p1 immunizations and challenge. Naı ¨ve
indicates uninfected, non-immunised or challenged mice. (A) Schematic of the transfer protocol and ﬂow cytometry plots showing the purity of
the MACS-sorted CD4
1 and CD4
  MLNC prior to transfer; (B) total cell numbers, (C) eosinophil numbers, (D) IL-5 levels and (E) eotaxin levels in BAL,
(F) total IgE, (G) Der p 1-speciﬁc IgE, (H) Der p 1-speciﬁc IgG1 and (I) Der p 1-speciﬁc IgG2a in serum. Data are means7SE from ﬁve individual mice
per group. Statistical analysis by the Mann–Whitney test: p o 0.04; p o 0.02; p o 0.004.
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donors, while transfer of naı ¨ve B cells had no effect (Fig. 4B). In
contrast, B-cell transfers exerted no inﬂuence on the overall levels
of serum IgE, or on allergen-speciﬁc IgE responses, as observed
previously in recipients of total CD4
  cell populations, and
neither total nor allergen-speciﬁc IgA were signiﬁcantly altered in
recipients of B cells from naı ¨ve or infected mice (data not shown).
CD4
þ and CD4
  cells from infected donors modulate
the severity of MOG(p35–55)-induced EAE
The capacity of helminth-induced cell populations to regulate
inﬂammatory disorders was further examined in an autoimmune
setting, in which myelin oligodendrocyte glycoprotein (MOG)
reactive T cells cause EAE. Using the CD45.1/2 adoptive transfer
system, we ﬁrst tested whether CD4
1or CD4
  populations from
the MLN of chronically infected B6-CD45.1 mice could inﬂuence
disease progression in uninfected MOG(p35–55)-immunized
C57BL/6-CD45.2 recipients. Mice were immunized on day 0
with MOG(35–55) in CFA and received either sterile PBS, 4 10
6
CD4
1 or 4 10
6 CD4
  cells from H. polygyrus-infected donors on
day 1. Pertussis toxin was given to all mice on days 0 and 2
(Fig. 5A). Progression of disease was monitored daily and
assessed using a clinical score based on tail, hind limb and front
limb paralysis as described in Materials and methods.
In two replicate experiments, CD4
1 cells from infected donors
were able to delay the onset of EAE and to reduce the severity of
clinical signs observed in the ﬁrst 2wk (Fig. 5B). Beyond this
time, in the recovery phase, the effect of CD4
1 cell transfer was
not reproducibly signiﬁcant. However, MOG(p35–55)-immunized
mice receiving CD4
  cells from infected donors consistently and
signiﬁcantly had a markedly lower clinical score, with a lower
incidence and maximal clinical score throughout the time course
observed, with an increased recovery rate in both experiments
(Fig. 5C). The transfer of either CD4
1 or CD4
  cells from
H. polygyrus-infected mice did not alter the balance of Th1/Th2
responsiveness, as judged by unchanged MOG-speciﬁc recall
splenocyte IFN-g and IL-4 responses in recipient mice (data not
shown).
CD4
þ and CD4
  cells from infected donors show
similar long-term survival following transfer
In view of the more extended protection against EAE accorded by
CD4
  cells, we compared the trafﬁcking and survival of donor
(CD45.1) cells in recipient mice 34 days after i.v. transfer of
chronically infected MLNC. We have established that transferred
B cells disseminate to many lymphoid tissues, but do not enter
the CNS even under conditions of EAE (S M Anderton,
unpublished). We therefore compared the numbers of donor
CD4+ CD4–
from H. polygyrus
infected donors
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Figure 2. Reduced airway pathology and inﬂammation following adoptive transfer of CD4
  cells from helminth-infected donors. Experiments
were performed as in Fig. 1A with transfer of puriﬁed CD4
1 and CD4
  MLNC from 28 day H.polygyrus-infected mice. (A) On day 32 lung sections
were stained with hematoxylin and eosin to measure cellular inﬂammation within the broncho-vascular bundles following airway challenge. D:D
denotes mice receiving Der p1 immunizations and challenge. Four individual mice are shown for each group. (B) Experiments were performed as in
Fig. 1Awith transfer of CD4
  cells from naı ¨ve or 28 day H.polygyrus-infected mice. Airway inﬂammation was measured by total cell and eosinophil
numbers in BAL. Statistical analysis by the Mann–Whitney test: p o 0.02.
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1CD45.1
1 (Fig. 5D) and CD4
 CD45.1
1 (Fig. 5E)
cells recovered from the spleen and LN draining the site of
immunization almost 5wk after transfer. These data indicate that
both cell types enjoy similar survival, and most likely proliferate,
within the adoptive host.
CD4
þ cells from infected WT and IL-10
 /  mice also
reduce the severity of EAE
To test the ability of helminth-induced B cells to modulate EAE, we
adoptively transferred CD19
1 cells from naı ¨ve, chronically infected
WT and IL-10
 /  donors, into the tail vein of MOG(35–55)-
immunized recipients. MOG(35–55)-immunized mice receiving
CD19
1 cells from infected donors, irrespective of IL-10 sufﬁciency,
were signiﬁcantly protected from EAE (Fig. 6). The onset of clinical
signs was delayed with the maximal clinical score substantially
reduced following the introduction of B cells from infected donors.
The complete recovery was increased by 40 and 100%, at 30 days
post-immunization, following the adoptive transfer of B cells from
infected WT or IL-10
 /  donors, respectively.
CD4
þ B cells from infected mice are phenotypically
similar to B2 cells and express high levels of CD23
The murine B-cell compartment is heterogeneous and can be
separated into distinct subsets using a number of parameters
including maturation stage, surface phenotype, anatomical
localization and state of activation. CD5 and B220 have
commonly been used to distinguish B1 and B2 cells, respectively
[48] and CD23, the intermediate afﬁnity IgE FcR, used to identify
B-cell activation [49].
To characterise the CD19
1 B cells from the MLN of chronically
infected mice, unseparated MLN and CD19-puriﬁed B cells were
recovered and stained with CD19, CD5 and B220 to differentiate
between B1 (CD5
int B220
int) and B2 (CD5
lowB220
hi) B-cell
populations. In addition we stained for CD43, a marker known to
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Figure 3. Donor cells trafﬁc to allergen-exposed airways, lung interstitium and local draining LN. Experiments were performed as in Fig 1A by
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  cells in BAL, lung and thoracic LN determined. Data are means7SE from ﬁve individual mice per group. Statistically signiﬁcant
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MLN or CD19
1 puriﬁed cells, the proportion of B1 cells in the
MLN diminished following 28 days of infection with H. polygyrus,
with very few CD43
1 cells remaining (Fig. 7A). CD19
1 B cells
from infected mice, moreover, showed uniformly elevated levels
of CD23, the low afﬁnity FceR (Fig. 8B), with MFI of infected cells
approximately twofold higher than cells from uninfected mice
(18057130 versus 854719, p50.0073). Infected MLNC
contained a higher proportion of IgD-negative B cells, although
little change was observed in CD21 expression (Fig. 8C). Few
CD1d-positive B cells were observed in either naı ¨ve or infected
MLNC populations (data not shown).
CD4
þ B cells from naı ¨ve and infected mice show
similar levels of activation
To assess whether infection resulted in a generalised
activation of mucosal-associated B cells, we also measured
expression of CD69 and CD86, two surface markers up-regulated
on activated B cells. Neither showed increased levels in B cells from
infected mice, and indeed a small downshift in CD69 expression
was evident in the population exposed to infection (Fig. 7D).
Responsiveness to non-speciﬁc activation (PMA with ionomycin) or
TLR ligation (with CpG) was also assessed, in terms of IL-6 and
IL-10 cytokine production. In general, whether testing MLN or
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Figure 4. CD19
1 cells inhibit allergen-induced airway inﬂammation, independent of donor IL-10. Experiments were performed as in Fig. 1A with
the transfer of puriﬁed CD19
1 cells from naı ¨ve, WT-infected and IL-10
 / -infected mice. (A) Total cell and eosinophil inﬁltration into the BALF. (B)
IL-5 and eotaxin concentrations in BALF and total IgE and Der p 1-speciﬁc IgE concentrations in serum. Data are means7SE from ﬁve individual
mice per group. Statistically signiﬁcant differences, assessed by the Mann–Whitney test: p o 0.04; p o 0.02.
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responses, particularly when co-stimulated with anti-CD40 anti-
body. However, the incremental effect was quite modest and there
was no clear qualitative difference between the B-cell sets from
naı ¨ve or infected mice (Fig. 8).
Discussion
Helminth parasites are strongly associated with polarized Th2
responses [51–54], and have evolved a spectrum of anti-
inﬂammatory mechanisms that limit immunopathology during
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Figure 5. CD4
1 and CD4
  cells from helminth-infected donors can also trafﬁc to CNS-draining LN and suppress MOG(p35–55)-induced EAE. Transfer
of 4 10
6 CD4
1 and CD4
  MLNC from day 28 H.polygyrus-infected B6-CD45.1 mice into C57BL/6 recipients that had been immunised with
MOG(p35–55) plus pertussis toxin (Ptx) 1 day before (day 0 in scheme). One day after transfer, Ptx was injected again; between 12 and 33 days later
(days 14 and 35, respectively) the mice were assessed for the development of EAE. (A) Experimental design of transfer. (B) Effect of transferred CD4
1
and CD4
  MLN cells from day 28-infected donors on MOG(p35–55)-induced EAE. (C) Summary of incidence, mortality and recovery from EAE of the
experiments presented in (B). Numbers of (D) CD4
1 and (E) CD4
  cells in the spleen and popliteal/inguinal LN. (D and E) Data in bar charts are
means7SE from ten individual mice per group, with representative ﬂow cytometry plots presented alongside.
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the role of CD4
1CD25
1 Treg has most clearly been substantiated
[23, 25, 26, 56]. However, during infection alternatively
activated macrophages, with the ability to dampen T-cell
responses [33, 34, 57], along with dendritic cells providing
negative signals to T cells [58], collectively suggest that a
broader-based regulatory environment takes shape during
helminth infections. Several studies in a range of systems have
identiﬁed B-cell populations with signiﬁcant regulatory potential
[35, 38, 47, 59, 60]. Recent reports demonstrating regulatory
activity of B cells in murine helminth infections [40, 43] have
been followed by a report associating CD19
1 B cells in helminth-
infected MS patients with limited disease progression [44].
We accordingly tested whether B cells with regulatory capa-
city are generated by a chronic helminth infection, extending our
earlier ﬁndings in the C57BL/6 strain, that both CD4
1CD25
1 and
CD4
  subsets from H. polygyrus-infected mice are able to down-
modulate allergic inﬂammation [23]. We found that, within the
MLNC of chronically-infected mice, the CD19
1 B-cell population
exerts a suppressive effect on airway allergy, and that suppres-
sion is mediated in an IL-10-independent manner. Importantly,
the inhibition of allergy cannot be attributed to a shift towards
Th1 responsiveness, as it is well-established that H. polygyrus
drives a strong Th2 response [23–25], and in our experiments no
diminution in IL-4 production or IgE levels was observed.
Furthermore, the same CD19
1 subset is able to down-regulate
inﬂammatory pathology in the Th1/Th17-mediated autoimmune
model of EAE, also in the absence of IL-10 capability. Antibody
levels in recipient animals were not signiﬁcantly altered by B-cell
transfer, suggesting that direct interactions with host cells may be
necessary for suppression. Phenotypically, CD19
1 B cells from
infected donors are predominantly follicular-type B2 cells (B220
1
CD5
 CD43
 ), and in vivo these cells are able to migrate to
inﬂammatory sites and local draining LN following adoptive
transfer.
Evidence is now building for an important role of B cells in
regulation during helminth infections, acting to cap the magni-
tude of inﬂammatory responses. Earlier work had shown that
Schistosoma mansoni infection of either mMT mice [61, 62] or
JHD mice [63], both of which are deﬁcient in B cells, leads to
increased ﬁbrosis, failure to down-modulate egg-induced granu-
lomas in the liver (a feature observed in B-cell-competent mice)
and a polarized Th1 response. These studies suggest that B cells
assist in restraining potentially pathogenic responses, a role also
ascribed to Treg cells in S. mansoni infection [64, 65]. More
recently, B cells taken from S. mansoni-infected donors were
shown to confer protection from Pen V-induced anaphylaxis and
airway allergy [43], in an IL-10-dependent manner [40], while
IL-10-secreting B cells were found to reduce antigen presentation
and T-cell-driven inﬂammation during ﬁlarial helminth infect-
ions [41].
B cells operate interactively across the whole spectrum of
immune system components [66], resulting in both direct and
indirect inﬂuences on the T-cell compartment. Functional B-cell
regulation of immunopathology has been established in EAE
[47, 67, 68], chronic intestinal inﬂammation [35] and systemic
lupus erythematosis [69, 70]. As antigen-presenting cells, B cells
may initiate [71] or tolerise [72] the T-cell response. Further-
more, B cells can modify dendritic cell-orchestrated T-cell
responses [73], indirectly interfering with T-cell activation and
effector function. Most recently, and in the context of H. poly-
gyrus infection, B cells have been shown to be major sources of
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tion, of course, B cells are responsible for the production of
antibodies, which are known to contribute towards immunity to
H. polygyrus in mice [76]. It is interesting to note that we
detected regulatory activity in B cells from C57BL/6 mice,
which are fully susceptible to H. polygyrus and are slow to mount
an antibody response, rather than from the more rapidly
responding BALB/c strain, which develops faster immunity to the
parasite.
In contrast to the above studies, we found that IL-10 is
dispensable for H. polygyrus-induced B-cell protection from both
airway allergy and EAE. Thus by both surface markers (CD5
 ,
CD23
hi) and by IL-10 independence, these helminth-induced
Breg are dissimilar to the ‘‘B10’’ IL-10-producing regulatory
B cells of the B1 or marginal zone type [37, 68]. We cannot
exclude a role for host IL-10 mediating protection, a scenario
observed with the adoptive transfer of OVA-speciﬁc Treg in a
similar allergy model [77], or more closely related to these
studies, adoptive transfer of apoptotic cell-exposed B cells licen-
sing the generation of host IL-10-secreting T cells [59]. Varying
dependence on IL-10 from helminth-induced B cells may reﬂect
the speciﬁc target organs or tissues studied in the different
systems. Moreover, immunological compensation may occur in
CD19
1 cells from H. polygyrus-infected IL-10
 /  donors, ampli-
fying other mediators, such as TGF-b, as seen in the CTLA-4-
deﬁcient setting [78]. Notably, TGF-b expression is elevated in
both CD4
1 and CD4
  MLNC during H. polygyrus infection [23],
and TGF-b signalling plays an important role in the T-cell
response to this parasite [79]. As TGF-b has previously been
associated with B-cell-regulatory function [36, 80], and is
responsible for the ability of B cells to induce functional, Foxp3-
expressing Treg cells [60, 81], the involvement of this mediator in
helminth-induced B-cell suppression of pathology remains an
attractive possibility.
A further factor in the suppression may be the uniformly high
expression of CD23 on B cells from chronically infected mice. CD23
is the low afﬁnity IgE receptor, expression of which is known to be
ampliﬁed in gastro-intestinal nematode infection [82] and is posi-
tively regulated by levels of IL-4, IL-13 and IgE [83], all of which
are elevated in H. polygyrus infection [53]. Furthermore, CD23
itself can have inhibitory effects on allergen-induced airway
inﬂammation, with transgenic over-expression of CD23 limiting
airway eosinophilia and airway hyper-responsiveness [84] and
augmented airway responses in CD23
 /  mice [85, 86].
An alternative hypothesis is that B-cell down-regulation acts in a
cell contact-dependent manner. FasL-expressing B cells, inducing
apoptosis of antigen-speciﬁc T cells, have been reported to down-
regulate airway inﬂammation [87], and signiﬁcantly during
S. mansoni infection this pathway of inducing T-cell apoptosis is
enhanced [88]. Together, these observations provide an additional
model of helminth-derived B-cell suppression of T-cell responses
that is likely to be relevant to the study presented here.
In conclusion, we have identiﬁed CD19
1CD23
hi B2 B cells, in
addition to CD4
1CD25
1 Treg cells [23], as important components
of the adaptive response to H. polygyrus infection, which have the
capacity to down-modulate inﬂammatory reactions. Indeed, B-cell
recruitment of Treg cells [89] might form a collaborative Treg–
B-cell interaction, which continues throughout the chronic phase of
infection. By including B cells within the interplay of immune
mechanisms that develop during helminth infections, we can
signiﬁcantly broaden our understanding of the regulatory envir-
onment that forms in chronic infections [90], with important
implications for the prospective exploitation of helminth products
to combat major immune-dependent inﬂammatory disorders.
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Animals
Female BALB/c, C57BL/6 and congenic CD45.1-allelic C57BL/6 mice
(B6-CD45.1), 6–8wk old, were housed in individually ventilated
cages). A minimum of ﬁve mice per group were used in each
experiment. IL-10-deﬁcient mice were on the C57BL/6 background
[91]. All experimental animals were conducted following institutional
ethical review and with authorisation of UK Home Ofﬁce licence.
Parasites
Mice were infected with 200 Heligmosomoides polygyrus bakeri
infective L3 larvae using a gavage tube. After 28 days of infection,
the chronicity of infection was conﬁrmed with eggs recoverable
from faecal pellets and gravid worms in the intestinal tract.
Antigens, allergens and antibodies
For H. polygyrus antigen, adult worms were homogenised in PBS,
followed by centrifugation (13000g for 10min). Supernatant
fractions were ﬁltered through a 0.2mm membrane (Millipore).
Antigen concentrations were determined by the Coomassie Plus
protein assay (Pierce). House dust mite allergen, Der p 1, was
afﬁnity-puriﬁed from spent mite medium using the monoclonal
antibody 4C1 (INDOOR Biotechnologies, UK), according to
published procedures [92]. Grade V Ovalbumin (A5503) was
purchased from Sigma, UK.
Allergen-induced airway inﬂammation
Mice were immunized by i.p. inoculation with 10mg Der p 1
(C57BL/6) adsorbed to 9% potassium alum (Sigma A7167), and
boosted again with 10mg Der p 1 in alum i.p. 14 days later. On
days 28 and 31, mice were anaesthetised with 20mL/g body
weight i.p. of a tribromoethanol anaesthetic, Avertin. Mice were
then given two airway challenges with 10mg Der p 1 in PBS by
the intratracheal route. Mice were killed 24h after the ﬁnal
airway challenge to assess airway inﬂammation. For histopatho-
logical analyses, formalin (4% paraformaldehyde in PBS) ﬁxed
lungs were processed and embedded in parafﬁn for sectioning.
Hematoxylin and eosin stains (Sigma, 03972) were used for
analysis of airway inﬂammation and pathological changes.
Induction and assessment of EAE
EAE was induced by immunization with 100mg of MOG(p35–55)
peptide emulsiﬁed in CFA containing 50mg of heat-killed
Mycobacterium tuberculosis H37RA (Sigma, Poole, Dorset, UK).
The emulsion was administered as two 50-mL subcutaneous
injections, one into each hind leg. Mice also received 200ng of
pertussis toxin (Speywood Pharmaceuticals, Maidenhead, UK)
intraperitoneally in 0.5mL of PBS on the same day and 2 days
later. Clinical signs of EAE were assessed daily in a blinded
fashion using a 0–6 scoring system (0, no signs; 1, ﬂaccid tail; 2,
impaired righting reﬂex and/or gait; 3, partial hind limb
paralysis; 4, total hind limb paralysis; 5, hind limb paralysis with
partial fore limb paralysis; 6, moribund or dead). Recovery
rates are referred to as the percentage of mice with no observable
clinical signs at day 30. Differences in total disease
burdens between groups were analyzed with the Mann–Whitney
U-test.
BALF and differential cell counts
Twenty-four hours after the ﬁnal challenge, mice were terminally
anaesthetised with ketamine (Vetalar V, Pharmacia & Upjohn)
and Xylazine (Rompun 2%, BAYER). The trachea was cannu-
lated, and internal airspaces lavaged with an initial 500mLo f
sterile PBS, followed by two 350mL washes. Fluids were
centrifuged at 1200g, and pellets recovered for cellular analysis.
The supernatants of the initial 500mL of BALF were stored at
 801C for biochemical analyses. Cytospins were prepared by
spinning 5 10
5 cells onto poly-(L-lysine) coated slides (BDH)
followed by Diff Quick
s (Boehringer, UK) staining. Differential
cell counts were performed at 100  magniﬁcation; a minimum
of 200 cells were counted for each slide.
Quantiﬁcation of allergen-speciﬁc antibodies and
total IgE
Allergen-speciﬁc responses were determined by ELISA. Multisorp
(NUNC) plates were coated with 4mg/mL Der p 1 diluted in
0.06M carbonate buffer, and incubated overnight at 41C. Plates
were blocked with 5% BSA (Fraction V, Gibco) for 2h at 371C.
Serum dilutions were added to plates in TBS, 0.05% Tween
(TBS-T) and incubated overnight at 41C. HRP-conjugated goat
anti-mouse IgG1 (1070–05) and anti-IgG2a (1080–05) (both
from Southern Biotech) and ABTS peroxidase substrate
(50–62–00, KPL) were used to detect allergen-speciﬁc IgG
isotypes. Prior to allergen-speciﬁc IgE assays, IgG was removed
from sera by overnight incubation with protein-G sepharose
beads; biotinylated anti-mouse IgE (Clone R35 118, BD
Pharmingen), ExtrAvidin-Alkaline phosphatase conjugate
(Sigma, E-2636) and pNPP Substrate (Sigma) were then used.
Total IgE was measured with anti-mouse IgE capture
antibody (clone R35–72, 553413, BD Pharmingen) and biotiny-
lated anti-mouse IgE detection antibody (clone R35–118,
553419), using a monoclonal IgE standard curve (clone 27–74,
553481).
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Cytokines were measured by ELISA according to suppliers’
guidelines as previously described [24]. Capture antibodies used
were: for IL-5, TRFK5, 2mg/mL; IL-6, MP5-20F3, 2mg/mL; IL-10,
JES5-2A5, 4mg/mL; eotaxin AF420NA, 0.4mg/mL. Biotinylated
detection antibodies were purchased from Pharmingen
for IL-5 (TRFK4, 2mg/mL), IL-6 (MP532C11, 0.5mg/mL) IL-10
(SXC-1, 2mg/mL) or R&D systems (Eotaxin, mAb BAF420,
0.4mg/mL).
CD4
1, CD4
  and CD19
1 isolation and adoptive transfer
MLN were removed from mice infected 28 days earlier with 200
H. polygyrus larvae. Single-cell suspensions in RPMI-0.5% normal
mouse serum were made using a cell strainer. For CD4
1 cell
puriﬁcation, cell suspensions were incubated with CD4 (L3T4)
microbeads (Miltenyi Biotech, Bisley UK 130–049–201) and
separated on two MACS LS separation columns (130–042–401)
to enhance purity after ﬁltering with pre-separation ﬁlters
(130–041–407); 4 10
6 CD4
1 or CD4
  cells were injected i.v.
into recipient mice. For CD19
1 cell puriﬁcation, MLNC were ﬁrst
incubated with CD19 microbeads (Miltenyi Biotech 130–052/
201) and separated on two MACS LS separation columns as
above. Uninfected, allergen-sensitized mice received cells from
infected donors 7 days before the ﬁrst airway challenge.
MOG(p35–55)-immunized mice received cells from infected donors
1 day after MOG(p35–55) immunization.
In vitro B-cell culture
Following a previously published protocol [93], single cell
suspensions from the MLN and spleens of naı ¨ve and infected
C57/BL6 mice, were prepared in complete Iscove’s modiﬁed
Dulbecco’s medium (cIMDM110%FCS11% penicillin/strepto-
mycin11% L-glutamine). Following red blood cell lysis, cell
preparations were labelled with anti-CD19 microbeads and
separated by positive selection on a magnetic column, according
to the manufacturer’s instructions (Miltenyi Biotech). Puriﬁed B
cells were cultured in triplicate at 5 10
6 cells/mL in cIMDM in
the presence or absence of anti-CD40 (clone FGK-45, 10mg/mL),
and either CpG (25mg/mL) or PMA and ionomycin (Sigma UK)
(50ng/mL and 1mg/mL respectively). Supernatants were
collected after 5 days and stored at  80
oC until used for cytokine
analysis.
Flow cytometry
Cells were stained with antibodies diluted in PBS with 0.5% BSA
(Sigma-Aldrich), 0.05% sodium azide (Sigma-Aldrich) for 20min
at 41C. For detection of CD4
1CD45.1
1 donor cells, monoclonal
rat anti-mouse CD4 (L3T4, clone RM4-5, Isotype Rat IgG2a) and
rat anti mouse-CD45.1 (Ly5.1, Clone A20, Isotype Mouse IgG2a)
were used. The expression of surface markers was analysed on
FACSCalibur or LSRII ﬂow cytometers using FlowJo software
(Tree Star). All ﬂuorochrome-labelled antibodies were obtained
from BD Pharmingen, unless otherwise stated. For detection of
B–cell-associated markers, the monoclonal rat IgG2a antibodies
were used to the following antigens: B220 (clone RA3 6B2), CD5
(Clone 53-7.3), CD19 (Clone 1D3, E-Bioscience), CD21 (Clone
7E9, BioLegend), CD23 (Clone B3B4, BioLegend), CD43 (Clone
1B11, BioLegend), CD69 (H1.2F3), CD86 (GL1) and IgD
(11–26c.2a).
Splenocyte and LN re-stimulation
Spleens or LN were immediately removed from recently killed
mice, sieved into single-cell suspensions in RPMI-0.5% normal
mouse serum using a cell strainer. Cells were incubated in
quadruplicate at 1 10
6 cells/well of a round-bottomed 96-well
plate in a total of 200mLa t3 7 1C. Supernatants were collected,
after 54h of culture, and stored at  801C for cytokine analysis.
Statistical analysis
The Mann–Whitney test was used for all statistical comparisons,
unless otherwise stated; p values o0.05 were considered
signiﬁcant.
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